MP:0002145 | abnormal T lymphocyte development | "atypical production of or inability to produce mature T cells, and/or accumulation of T cell precursors" [csmith:Cynthia L. Smith , Mouse Genome Informatics Curator] |
Show
Allelic Composition: In(9Bmp5-Myo6)5Rl/Bmp5se Myo6sv Genetic Background: involves: 101/Rl * C3H/Rl
|
MP:0002455 | abnormal dendritic cell antigen presentation | "impairment of these specialized cells to process and present antigen to T lymphoytes" [Immunobiology , The Immune System in Health and Disease:ISBN 0-8153-1691-7] |
Show
Allelic Composition: In(9Bmp5-Myo6)5Rl/Bmp5se Myo6sv Genetic Background: involves: 101/Rl * C3H/Rl
|
MP:0002459 | abnormal B cell physiology | "abnormal function of B lymphocytes" [cwg:Carroll-Ann W. Goldsmith , Mouse Genome Informatics curator] |
Show
Allelic Composition: In(9Bmp5-Myo6)5Rl/Bmp5se Myo6sv Genetic Background: involves: 101/Rl * C3H/Rl
|
MP:0004974 | decreased regulatory T cell number | "reduced number of the specialized subpopulation of T cells that act to suppress activation of the immune system and thus maintain immune system homeostasis and prevent pathological self-reactivity" [MGI:csmith "Cynthia L. Smith, Mouse Genome Informatics Curator"] |
Show
Allelic Composition: In(9Bmp5-Myo6)5Rl/Bmp5se Myo6sv Genetic Background: involves: 101/Rl * C3H/Rl
|
MP:0005042 | abnormal level of surface class II molecules | "deviation from the normal concentration of major histocompatibility complex class II molecules expressed at the cell surface" [cwg:Carroll-Ann W. Goldsmith , Mouse Genome Informatics curator] |
Show
Allelic Composition: In(9Bmp5-Myo6)5Rl/Bmp5se Myo6sv Genetic Background: involves: 101/Rl * C3H/Rl
|
MP:0005461 | abnormal dendritic cell morphology/development | "anomalous structure or atypical formation of the immunocompetent cells of the lymphoid and hemopoietic systems and skin, which function to process antigens and present them to T cells, thus stimulating cellular immunity" [cwg:Carroll-Ann W. Goldsmith , Mouse Genome Informatics curator, MeSH:National Library of Medicine - Medical Subject Headings , 2003] |
Show
Allelic Composition: In(9Bmp5-Myo6)5Rl/Bmp5se Myo6sv Genetic Background: involves: 101/Rl * C3H/Rl
|
MP:0008075 | decreased CD4-positive T cell number | "reduced number of the subset of T lymphocytes that carry the CD4 marker, recognize intravesicular peptides bound to MHC class-II molecules, and turn on antibody production" [MGI:csmith "Cynthia L. Smith, Mouse Genome Informatics Curator"] |
Show
Allelic Composition: Cd83tm1.1Lnjt/Cd83tm1.1Lnjt,March1tm1.1Sish/March1tm1.1Sish Genetic Background: involves: 129S1/Sv * 129X1/SvJ * C57BL/6 * C57BL/6N
|
MP:0008561 | decreased tumor necrosis factor secretion | "reduction in the production or release of a serum glycoprotein produced by activated macrophages and NK cells and involved in initiating local inflammatory responses, particularly by its action on the endothelium of local blood vessels; its actions result in increased vascular permeability and induction of expression of adhesion molecules on the endothelium" [ISBN:0-8153-1691-7 "Immunobiology, The Immune System in Health and Disease", MESH:D12.644.276.374.500.800] |
Show
Allelic Composition: In(9Bmp5-Myo6)5Rl/Bmp5se Myo6sv Genetic Background: involves: 101/Rl * C3H/Rl
Allelic Composition: March1tm1.1Sish/March1tm1.1Sish Genetic Background: involves: 129S1/Sv * 129X1/SvJ
|
MP:0008664 | decreased interleukin-12 secretion | "reduction in the production or release of a heterodimeric cytokine that plays a role in innate and adaptive immune responses; it is produced by dendritic cells, macrophages and a variety of other immune cells and plays a role in the stimulation of interferon-gamma production by T-cells and natural killer cells" [MESH:D12.644.276.374.465.512] |
Show
Allelic Composition: In(9Bmp5-Myo6)5Rl/Bmp5se Myo6sv Genetic Background: involves: 101/Rl * C3H/Rl
Allelic Composition: March1tm1.1Sish/March1tm1.1Sish Genetic Background: involves: 129S1/Sv * 129X1/SvJ
|